| bimatoprost / Generic mfg. |
NCT01189279: Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia |
|
|
| Completed | 1 | 42 | US | bimatoprost Formulation A, bimatoprost Formulation B, bimatoprost Formulation C | Allergan | Alopecia, Alopecia, Androgenetic, Baldness | 01/11 | 02/11 | | |
NCT02848300: Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia |
|
|
| Completed | 1 | 11 | US | Bimatoprost 1% Formulation A, Bimatoprost 1% Formulation B | Allergan | Androgenetic Alopecia | 10/16 | 10/16 | | |
NCT02676310: Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) |
|
|
| Terminated | 1 | 53 | US | Bimatoprost, Bimatoprost Solution applied onto pre-specified area on the scalp daily for 28 days. | Allergan | Alopecia, Alopecia, Androgenetic, Baldness | 01/17 | 03/17 | | |
NCT02830776: Topical Bimatoprost for Chemical Blepharoplasty |
|
|
| Completed | 1 | 15 | US | bimatoprost 0.03% ophthalmic solution, Latisse | Tulane University, Allergan | Dermatochalasis | 04/17 | 06/17 | | |
NCT04738149: Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment |
|
|
| Completed | 1 | 4 | US | Bimatoprost, Excimer laser, Microneedling with a dermaroller | Medical University of South Carolina | Vitiligo | 05/22 | 05/22 | | |
NCT05729594: Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers |
|
|
| Completed | 1 | 40 | US | Bimatoprost Ophthalmic | Laboratoires Thea | Healthy Volunteers | 04/23 | 04/23 | | |
NCT06267274: A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes |
|
|
| Recruiting | 1 | 240 | US | Bimatoprost Ophthalmic Solution, 0.01%, LUMIGAN® (bimatoprost ophthalmic solution) 0.01% | Amneal Pharmaceuticals, LLC, CBCC Global Inc., Amneal EU, Limited | Open-angle Glaucoma, Ocular Hypertension | 03/25 | 05/25 | | |
NCT03708627: Bimatoprost as a Treatment for Graves' Orbitopathy |
|
|
| Recruiting | 1 | 3 | US | Bimatoprost Ophthalmic | Johns Hopkins University | Graves Ophthalmopathy | 07/29 | 07/31 | | |
